Zachary Spencer Dunn

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Derek Lee, Zachary Spencer Dunn, Wenbin Guo, Carl J Rosenthal, Natalie E Penn, Yanqi Yu, Kuangyi Zhou, Zhe Li, Feiyang Ma, Miao Li, Tsun-Ching Song, Xinjian Cen, Yan-Ruide Li, Jin J Zhou, Matteo Pellegrini, Pin Wanga, Lili Yang
Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering. Nature communications 14 (1) (2023)
Yan-Ruide Li, James Brown, Yanqi Yu, Derek Lee, Kuangyi Zhou, Zachary Spencer Dunn, Ryan Hon, Matthew Wilson, Adam Kramer, Yichen Zhu, Ying Fang, Lili Yang
Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity. Cancers 14 (11) (2022)
Zachary Spencer Dunn, Yan-Ruide Li, Yanqi Yu, Derek Lee, Alicia Gibbons, James Joon Kim, Tian Yang Zhou, Mulin Li, Mya Nguyen, Xinjian Cen, Yang Zhou, Pin Wang, Lili Yang
Minimally Invasive Preclinical Monitoring of the Peritoneal Cavity Tumor Microenvironment. Cancers 14 (7) (2022)
Yang Zhou, Miao Li, Kuangyi Zhou, James Brown, Tasha Tsao, Xinjian Cen, Tiffany Husman, Aarushi Bajpai, Zachary Spencer Dunn, Lili Yang
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy. Cancers 14 (9) (2022)
Derek Lee, Carl J Rosenthal, Natalie E Penn, Zachary Spencer Dunn, Yang Zhou, Lili Yang
Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy. Cancers 14 (12) (2022)
Yan-Ruide Li, Zachary Spencer Dunn, Yang Zhou, Derek Lee, Lili Yang
Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies. Cells 10 (12) (2021)